Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs Direct Meds

Two GLP-1 desks, one scoreboard. We put Sprout Health and Direct Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 6 · Grade B

Sprout Health

Visit Sprout Health Full brief →

FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.

vs
No. 30 · Grade B−

Direct Meds

Visit Direct Meds Full brief →

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 82 on our six-factor Brief Score — A LegitScript-certified provider that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
80
Supply Reliability
82
80
Transparency
88
78
Access Breadth
92
84
Clinical Oversight
78
83
Track Record
84
78
Sprout HealthBrief Score 86 · 82Direct Meds

Price, coverage & the tracker

Sprout HealthDirect Meds
Brief Score86/100 (B)82/100 (B−)
Semaglutide$299/mo$249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment
Tirzepatide$349/mo$299/mo sublingual · $399/mo injectable — both billed monthly on a 3-month minimum commitment
CoverageNot disclosedNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

Sprout Health: The standing compounded rates are $299 semaglutide / $349 tirzepatide; the $149/$199 on the home page are first-month-only prices under code FIRST150. A brand-name Wegovy/Zepbound path is available on the same account.

Direct Meds: Company-stated rates unchanged this cycle — but we price these off the provider's own listings, not a live-verified checkout, so treat them as indicative.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.